Literature DB >> 17569747

APRIL polymorphism and systemic lupus erythematosus (SLE) susceptibility.

Y H Lee1, F Ota, X Kim-Howard, K M Kaufman, S K Nath.   

Abstract

OBJECTIVE: Two novel non-synonymous polymorphisms of the APRIL gene, codon 67 (rs11552708) and 96 (rs3803800), were recently identified and tested for disease association. The 67G allele was reported to be associated with systemic lupus erythematosus (SLE) in a Japanese population. The aim of the study is to investigate whether the APRIL polymorphism associated with susceptibility to SLE in a Japanese population is associated with the susceptibility to SLE in other ethnic groups.
METHODS: Three hundred and forty-eight SLE patients (204 European-American, 103 African-American and 41 Hispanic) and 345 ethnicity-matched controls (201 European-American, 104 African-American and 40 Hispanic) were included from the Lupus Multiplex Registry and Repository (LMRR) and evaluated for genetic association. The APRIL codon 67 and codon 96 were genotyped by a 3-base extension method. Statistical evaluations were performed using both chi-square and logistic regression analysis.
RESULTS: Both the single-nucleotide polymorphisms (SNPs) were in Hardy-Weinberg equilibrium in cases and controls within each ethnic group. The APRIL codon 67 was significantly associated with SLE risk under the dominant model adjusted by ethnicity (odds ratio, 95% confidence interval and P-values were 1.45 and 1.02-2.06 and 0.036, respectively). Race-specific analysis also showed a trend for association in African-American and Hispanic SLE subjects. CONCLUSION The APRIL codon G67R polymorphism associated with SLE in a Japanese population may also be associated with SLE in other populations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17569747     DOI: 10.1093/rheumatology/kem093

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  7 in total

Review 1.  Future prospects in biologic therapy for systemic lupus erythematosus.

Authors:  William Stohl
Journal:  Nat Rev Rheumatol       Date:  2013-09-10       Impact factor: 20.543

2.  APRIL gene polymorphism and serum sAPRIL levels in children with systemic lupus erythematosus.

Authors:  Shideh Namazi; Nader Tajik; Vahid Ziaee; Maryam Sadr; Samaneh Soltani; Arezou Rezaei; Samaneh Zoghi; Nima Rezaei
Journal:  Clin Rheumatol       Date:  2016-11-23       Impact factor: 2.980

Review 3.  The BAFF/APRIL system in SLE pathogenesis.

Authors:  Fabien B Vincent; Eric F Morand; Pascal Schneider; Fabienne Mackay
Journal:  Nat Rev Rheumatol       Date:  2014-03-11       Impact factor: 20.543

4.  Protein and functional isoform levels and genetic variants of the BAFF and APRIL pathway components in systemic lupus erythematosus.

Authors:  Pilar Ortiz-Aljaro; Marco Antonio Montes-Cano; José-Raúl García-Lozano; Virginia Aquino; Rosario Carmona; Javier Perez-Florido; Francisco José García-Hernández; Joaquín Dopazo; María Francisca González-Escribano
Journal:  Sci Rep       Date:  2022-07-02       Impact factor: 4.996

Review 5.  Cytokine disturbances in systemic lupus erythematosus.

Authors:  Noam Jacob; William Stohl
Journal:  Arthritis Res Ther       Date:  2011-07-06       Impact factor: 5.156

6.  Genome-wide scan identifies variant in TNFSF13 associated with serum IgM in a healthy Chinese male population.

Authors:  Ming Yang; Yongming Wu; Yanmei Lu; Changyuan Liu; Jielin Sun; Ming Liao; Min Qin; Linjian Mo; Yong Gao; Zheng Lu; Chunlei Wu; Youjie Zhang; Haiying Zhang; Xue Qin; Yanling Hu; Shijun Zhang; Jianling Li; Min Dong; S Lilly Zheng; Jianfeng Xu; Xiaobo Yang; Aihua Tan; Zengnan Mo
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

7.  Association Study of a Proliferation-inducing Ligand, Spermatogenesis Associated 8, Platelet-derived Growth Factor Receptor-alpha, and POLB Polymorphisms with Systemic Lupus Erythematosus in Chinese Han Population.

Authors:  Ping Li; Yuan Li; Ai-Hong Zhou; Si Chen; Jing Li; Xiao-Ting Wen; Zi-Yan Wu; Liu-Bing Li; Feng-Chun Zhang; Yong-Zhe Li
Journal:  Chin Med J (Engl)       Date:  2016-09-05       Impact factor: 2.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.